{
  "created_at": "2020-10-24T01:14:48.000Z",
  "updated_at": "2021-01-06T08:25:11.356Z",
  "id": "cb17fcdb-a9c9-4355-8c0f-47e95e51c804",
  "labels": "current-affairs,2020-10-25",
  "question": "Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?",
  "option1": "Bharat Biotechnology",
  "option2": "Serum Institute",
  "option3": "Cipla",
  "option4": "Ranbaxy",
  "option5": "",
  "answer": "Serum Institute",
  "explanation": "The Pune based Serum Institute of India has partnered with Merck KGaA and IAVI for development SARS-CoV-2 neutralising monoclonal antibodies. The Merck Group is a German multinational science and technology company. <br />The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership working to accelerate the development of vaccines to prevent HIV infection and AIDS."
}